Indomethacin therapy in infants with advanced postnatal age and patent ductus arteriosus

B. Achanti, T. F. Yeh, R. S. Pildes

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

A trial of intravenous indomethacin therapy was performed on 11 premature infants whose postnatal age was 8 weeks or more (mean 65.3 days). In an attempt to maintain the desired plasma level, indomethacin was given at a dosage of 0.3 mg/kg, at 8-hour intervals (total dose 0.9 mg/kg) for a total of 3 doses. In spite of desirable plasma indomethacin levels (which ranged from 280-870 ng/ml) and area under the curve (24.1 μg/hr/ml), calculated from time to 0 to 24 hrs after the initial dose, none of the infants responded to indomethacin with ductus closure. There were a transient significant decrease in urine output, creatinine clearance, and fractional excretion of sodium. The present study confirms the clinical impression that Indomethacin is ineffective for the closure of ductus arteriosus in infants with advanced postnatal age.

Original languageEnglish
Pages (from-to)250-253
Number of pages4
JournalClinical and Investigative Medicine
Volume9
Issue number4
Publication statusPublished - Dec 1 1986
Externally publishedYes

Fingerprint

Patent Ductus Arteriosus
Indomethacin
Therapeutics
Ductus Arteriosus
Premature Infants
Area Under Curve
Creatinine
Sodium
Urine

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Indomethacin therapy in infants with advanced postnatal age and patent ductus arteriosus. / Achanti, B.; Yeh, T. F.; Pildes, R. S.

In: Clinical and Investigative Medicine, Vol. 9, No. 4, 01.12.1986, p. 250-253.

Research output: Contribution to journalArticle

@article{de773651570f490cb4722fecc2b06d1b,
title = "Indomethacin therapy in infants with advanced postnatal age and patent ductus arteriosus",
abstract = "A trial of intravenous indomethacin therapy was performed on 11 premature infants whose postnatal age was 8 weeks or more (mean 65.3 days). In an attempt to maintain the desired plasma level, indomethacin was given at a dosage of 0.3 mg/kg, at 8-hour intervals (total dose 0.9 mg/kg) for a total of 3 doses. In spite of desirable plasma indomethacin levels (which ranged from 280-870 ng/ml) and area under the curve (24.1 μg/hr/ml), calculated from time to 0 to 24 hrs after the initial dose, none of the infants responded to indomethacin with ductus closure. There were a transient significant decrease in urine output, creatinine clearance, and fractional excretion of sodium. The present study confirms the clinical impression that Indomethacin is ineffective for the closure of ductus arteriosus in infants with advanced postnatal age.",
author = "B. Achanti and Yeh, {T. F.} and Pildes, {R. S.}",
year = "1986",
month = "12",
day = "1",
language = "English",
volume = "9",
pages = "250--253",
journal = "Clinical and Investigative Medicine",
issn = "0147-958X",
publisher = "The Canadian Society for Clinical Investigation",
number = "4",

}

TY - JOUR

T1 - Indomethacin therapy in infants with advanced postnatal age and patent ductus arteriosus

AU - Achanti, B.

AU - Yeh, T. F.

AU - Pildes, R. S.

PY - 1986/12/1

Y1 - 1986/12/1

N2 - A trial of intravenous indomethacin therapy was performed on 11 premature infants whose postnatal age was 8 weeks or more (mean 65.3 days). In an attempt to maintain the desired plasma level, indomethacin was given at a dosage of 0.3 mg/kg, at 8-hour intervals (total dose 0.9 mg/kg) for a total of 3 doses. In spite of desirable plasma indomethacin levels (which ranged from 280-870 ng/ml) and area under the curve (24.1 μg/hr/ml), calculated from time to 0 to 24 hrs after the initial dose, none of the infants responded to indomethacin with ductus closure. There were a transient significant decrease in urine output, creatinine clearance, and fractional excretion of sodium. The present study confirms the clinical impression that Indomethacin is ineffective for the closure of ductus arteriosus in infants with advanced postnatal age.

AB - A trial of intravenous indomethacin therapy was performed on 11 premature infants whose postnatal age was 8 weeks or more (mean 65.3 days). In an attempt to maintain the desired plasma level, indomethacin was given at a dosage of 0.3 mg/kg, at 8-hour intervals (total dose 0.9 mg/kg) for a total of 3 doses. In spite of desirable plasma indomethacin levels (which ranged from 280-870 ng/ml) and area under the curve (24.1 μg/hr/ml), calculated from time to 0 to 24 hrs after the initial dose, none of the infants responded to indomethacin with ductus closure. There were a transient significant decrease in urine output, creatinine clearance, and fractional excretion of sodium. The present study confirms the clinical impression that Indomethacin is ineffective for the closure of ductus arteriosus in infants with advanced postnatal age.

UR - http://www.scopus.com/inward/record.url?scp=0022830014&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022830014&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 250

EP - 253

JO - Clinical and Investigative Medicine

JF - Clinical and Investigative Medicine

SN - 0147-958X

IS - 4

ER -